E Fund Management’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$322K	Buy	+25,110	New	+$320K	0.01%	376
2025 Q2	$135K	Sell	14,339 -2,492	-15%	-$20.5K	0.01%	369
2025 Q1	$120K	Sell	16,831 -1,222	-7%	-$12.3K	0.01%	379
2024 Q4	$210K	Buy	18,053 +1,634	+10%	+$25.5K	0.01%	357
2024 Q3	$337K	Buy	16,419 +3,754	+30%	+$86.6K	0.02%	239
2024 Q2	$283K	Sell	12,665 -1,795	-12%	-$42.7K	0.02%	241
2024 Q1	$398K	Sell	14,460 -2,091	-13%	-$58.1K	0.02%	222
2023 Q4	$505K	Buy	16,551 +4,476	+37%	+$129K	0.03%	161
2023 Q3	$382K	Buy	12,075 +1,745	+17%	+$67.7K	0.03%	174
2023 Q2	$421K	Sell	10,330 -452	-4%	-$18.3K	0.03%	157
2023 Q1	$402K	Sell	10,782 -321	-3%	-$12.6K	0.03%	165
2022 Q4	$387K	Buy	11,103 +3,710	+50%	+$176K	0.03%	191
2022 Q3	$414K	Sell	7,393 -2,922	-28%	-$181K	0.04%	173
2022 Q2	$534K	Buy	10,315 +5,938	+136%	+$302K	0.05%	133
2022 Q1	$318K	Buy	+4,377	New	+$371K	0.01%	181